CC
The Chemours Company
Chemicals - Specialty
Market Cap$3.36B
5Y Perf.+75.7%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
CC vs ASIX vs TROX vs KRO
Revenue, margins, valuation, and 5-year total return — side by side.
ASIX
AdvanSix Inc.
Chemicals
Market Cap$796M
5Y Perf.+71.6%
TROX
Tronox Holdings plc
Chemicals
Market Cap$1.34B
5Y Perf.+32.8%
KRO
Kronos Worldwide, Inc.
Chemicals - Specialty
Market Cap$811M
5Y Perf.-25.3%
CC vs ASIX vs TROX vs KRO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CC | ASIX | TROX | KRO |
|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals | Chemicals | Chemicals - Specialty |
| Market Cap | $3.36B | $796M | $1.34B | $811M |
| Revenue (TTM) | $5.82B | $1.52B | $2.92B | $1.88B |
| Net Income (TTM) | $-411M | $49M | $-359M | $-134M |
| Gross Margin | 15.1% | 10.8% | 5.8% | 10.1% |
| Operating Margin | -0.8% | 4.2% | -4.8% | -3.1% |
| Forward P/E | 15.9x | 15.7x | — | — |
| Total Debt | $4.58B | $381M | $3.59B | $577M |
| Cash & Equiv. | $672M | $20M | $211M | $37M |
CC vs ASIX vs TROX vs KRO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CC
ASIX
TROX
KRO
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| The Chemours Company (CC) | 100 | 175.7 | +75.7% |
| AdvanSix Inc. (ASIX) | 100 | 171.6 | +71.6% |
| Tronox Holdings plc (TROX) | 100 | 132.8 | +32.8% |
| Kronos Worldwide, I… (KRO) | 100 | 74.7 | -25.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CC vs ASIX vs TROX vs KRO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: ASIX leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. The Chemours Company is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. TROX also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
CC
The Chemours Company
The Growth Play
CC is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 0.4%, EPS growth -5.5%, 3Y rev CAGR -5.3%
- 219.7% 10Y total return vs KRO's 129.0%
- 0.4% revenue growth vs TROX's -5.7%
- +108.8% vs KRO's -1.2%
Best for: growth exposure and long-term compounding
ASIX
AdvanSix Inc.
The Income Pick
ASIX carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.81, yield 2.6%
- Lower volatility, beta 0.81, Low D/E 46.7%, current ratio 1.13x
- Better valuation composite
- 3.2% margin vs TROX's -12.3%
Best for: income & stability and sleep-well-at-night
TROX
Tronox Holdings plc
The Income Pick
TROX is the clearest fit if your priority is dividends.
- 3.6% yield, vs CC's 2.3%
Best for: dividends
KRO
Kronos Worldwide, Inc.
The Defensive Pick
KRO is the clearest fit if your priority is defensive.
- Beta 1.57, yield 2.8%, current ratio 2.70x
Best for: defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CC | 0.4% revenue growth vs TROX's -5.7% |
| Value | ASIX | Better valuation composite |
| Quality / Margins | ASIX | 3.2% margin vs TROX's -12.3% |
| Stability / Safety | ASIX | Beta 0.81 vs TROX's 2.37, lower leverage |
| Dividends | TROX | 3.6% yield, vs CC's 2.3% |
| Momentum (1Y) | CC | +108.8% vs KRO's -1.2% |
| Efficiency (ROA) | ASIX | 2.9% ROA vs KRO's -9.4%, ROIC 4.4% vs -1.9% |
CC vs ASIX vs TROX vs KRO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FY 2025
FY 2014
CC vs ASIX vs TROX vs KRO — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLASIXLAGGINGKRO
Who Leads Where
ASIX leads in 4 of 6 categories
TROX leads 1 • CC leads 0 • KRO leads 0 • 1 tied
Explore the data ↓KROKronos Worldwide, Inc.
0leads
CCThe Chemours Company
0leads
TROXTronox Holdings plc
1leads
ASIXAdvanSix Inc.
4leads
6 Total Categories
CATEGORYLEADERvs TROXvs CCMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
ASIX3/6
Valuation MetricsMultiples, price ratios, and targets
ASIX3/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ASIX9/9
Total Returns1Y, 3Y, 5Y total returns with dividends
Tied
—
Risk & VolatilityBeta, volatility, and downside exposure
ASIX2/2
Analyst OutlookRatings, price targets, and dividends
TROX1/1
Income & Cash Flow (Last 12 Months)
ASIX leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CC is the larger business by revenue, generating $5.8B annually — 3.8x ASIX's $1.5B. ASIX is the more profitable business, keeping 3.2% of every revenue dollar as net income compared to TROX's -12.3%. On growth, ASIX holds the edge at +9.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CCThe Chemours Comp… | ASIXAdvanSix Inc. | TROXTronox Holdings p… | KROKronos Worldwide,… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $5.8B | $1.5B | $2.9B | $1.9B |
| EBITDAEarnings before interest/tax | -$132M | $143M | $166M | -$9M |
| Net IncomeAfter-tax profit | -$411M | $49M | -$359M | -$134M |
| Free Cash FlowCash after capex | $198M | $6M | -$139M | $35M |
| Gross MarginGross profit ÷ Revenue | +15.1% | +10.8% | +5.8% | +10.1% |
| Operating MarginEBIT ÷ Revenue | -0.8% | +4.2% | -4.8% | -3.1% |
| Net MarginNet income ÷ Revenue | -7.1% | +3.2% | -12.3% | -7.1% |
| FCF MarginFCF ÷ Revenue | +3.4% | +0.4% | -4.8% | +1.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.0% | +9.4% | +3.0% | +4.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -6.1% | -8.8% | +7.1% | -126.1% |
ASIX leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
ASIX leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, ASIX's 7.9x EV/EBITDA is more attractive than KRO's 40.7x.
| Metric | CCThe Chemours Comp… | ASIXAdvanSix Inc. | TROXTronox Holdings p… | KROKronos Worldwide,… |
|---|---|---|---|---|
| Market CapShares × price | $3.4B | $796M | $1.3B | $811M |
| Enterprise ValueMkt cap + debt − cash | $7.3B | $1.2B | $4.7B | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | -8.75x | 13.34x | -2.83x | -7.34x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.86x | 15.74x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | 7.10x | — | — |
| EV / EBITDAEnterprise value multiple | 21.72x | 7.86x | 16.80x | 40.71x |
| Price / SalesMarket cap ÷ Revenue | 0.58x | 0.52x | 0.46x | 0.44x |
| Price / BookPrice ÷ Book value/share | 13.44x | 0.80x | 0.92x | 1.08x |
| Price / FCFMarket cap ÷ FCF | 65.93x | 124.10x | — | — |
ASIX leads this category, winning 3 of 6 comparable metrics.
Profitability & Efficiency
ASIX leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
ASIX delivers a 6.0% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $-163 for CC. ASIX carries lower financial leverage with a 0.47x debt-to-equity ratio, signaling a more conservative balance sheet compared to CC's 18.27x. On the Piotroski fundamental quality scale (0–9), ASIX scores 6/9 vs TROX's 2/9, reflecting solid financial health.
| Metric | CCThe Chemours Comp… | ASIXAdvanSix Inc. | TROXTronox Holdings p… | KROKronos Worldwide,… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | -163.4% | +6.0% | -30.4% | -17.0% |
| ROA (TTM)Return on assets | -5.5% | +2.9% | -7.7% | -9.4% |
| ROICReturn on invested capital | -0.1% | +4.4% | -0.3% | -1.9% |
| ROCEReturn on capital employed | -0.1% | +5.3% | -0.4% | -2.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 2 | 5 |
| Debt / EquityFinancial leverage | 18.27x | 0.47x | 2.48x | 0.77x |
| Net DebtTotal debt minus cash | $3.9B | $361M | $3.4B | $540M |
| Cash & Equiv.Liquid assets | $672M | $20M | $211M | $37M |
| Total DebtShort + long-term debt | $4.6B | $381M | $3.6B | $577M |
| Interest CoverageEBIT ÷ Interest expense | 1.15x | 7.92x | -1.16x | -2.32x |
ASIX leads this category, winning 9 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
Evenly matched — CC and KRO each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ASIX five years ago would be worth $8,411 today (with dividends reinvested), compared to $4,493 for TROX. Over the past 12 months, CC leads with a +108.8% total return vs KRO's -1.2%. The 3-year compound annual growth rate (CAGR) favors KRO at -0.2% vs ASIX's -9.4% — a key indicator of consistent wealth creation.
| Metric | CCThe Chemours Comp… | ASIXAdvanSix Inc. | TROXTronox Holdings p… | KROKronos Worldwide,… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | +83.6% | +40.3% | +98.1% | +58.5% |
| 1-Year ReturnPast 12 months | +108.8% | +8.2% | +76.9% | -1.2% |
| 3-Year ReturnCumulative with dividends | -15.7% | -25.6% | -23.6% | -0.7% |
| 5-Year ReturnCumulative with dividends | -22.7% | -15.9% | -55.1% | -43.9% |
| 10-Year ReturnCumulative with dividends | +219.7% | +60.6% | +116.1% | +129.0% |
| CAGR (3Y)Annualised 3-year return | -5.5% | -9.4% | -8.6% | -0.2% |
Evenly matched — CC and KRO each lead in 2 of 6 comparable metrics.
Risk & Volatility
ASIX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ASIX is the less volatile stock with a 0.81 beta — it tends to amplify market swings less than TROX's 2.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ASIX currently trades 89.8% from its 52-week high vs CC's 78.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CCThe Chemours Comp… | ASIXAdvanSix Inc. | TROXTronox Holdings p… | KROKronos Worldwide,… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.81x | 0.67x | 2.38x | 1.62x |
| 52-Week HighHighest price in past year | $28.67 | $26.73 | $10.59 | $7.90 |
| 52-Week LowLowest price in past year | $9.13 | $14.10 | $2.86 | $4.08 |
| % of 52W HighCurrent price vs 52-week peak | +78.1% | +89.8% | +79.4% | +89.2% |
| RSI (14)Momentum oscillator 0–100 | 48.1 | 60.6 | 58.5 | 63.4 |
| Avg Volume (50D)Average daily shares traded | 3.1M | 453K | 3.1M | 350K |
ASIX leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
TROX leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: CC as "Hold", ASIX as "Buy", TROX as "Buy", KRO as "Hold". Consensus price targets imply 7.7% upside for CC (target: $24) vs -29.1% for KRO (target: $5). For income investors, TROX offers the higher dividend yield at 3.60% vs CC's 2.31%.
| Metric | CCThe Chemours Comp… | ASIXAdvanSix Inc. | TROXTronox Holdings p… | KROKronos Worldwide,… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $24.14 | $22.00 | $7.50 | $5.00 |
| # AnalystsCovering analysts | 20 | 6 | 17 | 7 |
| Dividend YieldAnnual dividend ÷ price | +2.3% | +2.6% | +3.6% | +2.8% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.52 | $0.63 | $0.30 | $0.20 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | 0.0% | 0.0% |
TROX leads this category, winning 1 of 1 comparable metric.
Key Takeaway
ASIX leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). TROX leads in 1 (Analyst Outlook). 1 tied.
Best OverallAdvanSix Inc. (ASIX)Leads 4 of 6 categories
Loading custom metrics...
CC vs ASIX vs TROX vs KRO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CC or ASIX or TROX or KRO a better buy right now?
For growth investors, The Chemours Company (CC) is the stronger pick with 0.
4% revenue growth year-over-year, versus -5. 7% for Tronox Holdings plc (TROX). AdvanSix Inc. (ASIX) offers the better valuation at 13. 3x trailing P/E (15. 7x forward), making it the more compelling value choice. Analysts rate AdvanSix Inc. (ASIX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CC or ASIX or TROX or KRO?
On forward P/E, AdvanSix Inc.
is actually cheaper at 15. 7x.
03Which is the better long-term investment — CC or ASIX or TROX or KRO?
Over the past 5 years, AdvanSix Inc.
(ASIX) delivered a total return of -15. 9%, compared to -55. 1% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: CC returned +226. 5% versus ASIX's +38. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CC or ASIX or TROX or KRO?
By beta (market sensitivity over 5 years), AdvanSix Inc.
(ASIX) is the lower-risk stock at 0. 67β versus Tronox Holdings plc's 2. 38β — meaning TROX is approximately 257% more volatile than ASIX relative to the S&P 500. On balance sheet safety, AdvanSix Inc. (ASIX) carries a lower debt/equity ratio of 47% versus 18% for The Chemours Company — giving it more financial flexibility in a downturn.
05Which is growing faster — CC or ASIX or TROX or KRO?
By revenue growth (latest reported year), The Chemours Company (CC) is pulling ahead at 0.
4% versus -5. 7% for Tronox Holdings plc (TROX). On earnings-per-share growth, the picture is similar: AdvanSix Inc. grew EPS 11. 1% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, KRO leads at -1. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CC or ASIX or TROX or KRO?
AdvanSix Inc.
(ASIX) is the more profitable company, earning 3. 2% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ASIX leads at 4. 4% versus -1. 7% for KRO. At the gross margin level — before operating expenses — CC leads at 15. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CC or ASIX or TROX or KRO more undervalued right now?
On forward earnings alone, AdvanSix Inc.
(ASIX) trades at 15. 7x forward P/E versus 15. 9x for The Chemours Company — 0. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CC: 7. 7% to $24. 14.
08Which pays a better dividend — CC or ASIX or TROX or KRO?
All stocks in this comparison pay dividends.
Tronox Holdings plc (TROX) offers the highest yield at 3. 6%, versus 2. 3% for The Chemours Company (CC).
09Is CC or ASIX or TROX or KRO better for a retirement portfolio?
For long-horizon retirement investors, AdvanSix Inc.
(ASIX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 67), 2. 6% yield). Tronox Holdings plc (TROX) carries a higher beta of 2. 38 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ASIX: +38. 4%, TROX: +123. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CC and ASIX and TROX and KRO?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CC is a small-cap quality compounder stock; ASIX is a small-cap deep-value stock; TROX is a small-cap income-oriented stock; KRO is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(CC: 1.0% · ASIX: 9.4%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.